Freelance staff management platform WorkMarket has taken its total funding to $66m in a round that added Accenture to its shareholder list.

The WuXi PharmaTech-backed molecular diagnostics technology developer has raised $27m that will go to commercialising its IDgenetix product.

The clinical trials technology provider has now raised more than $66m in the space of 18 months, attracting GV, Sanofi Ventures, Amgen Ventures and DRx Capital for its latest round.

The cloud-based drug prescription platform has closed a round that included new investor GV and SR One, a backer since seed stage.

Aetna Ventures, GV and MassMutual Ventures have committed funds to the latest round for cyberthreat detection platform CyberGRX.

Boston Scientific has led a $23.1m series B round for Neurotronik, a medical device devloper focusing on patients suffering from heart failure.

The SIG-led round will enable the platform to expand its training content, boost its consultancy services and drive recruitment for its sales team.

Comcast Ventures has returned for the student loan provider's $30m series D round, having backed its $20m series C last year.

Comcast has reportedly led a funding round for the adaptive wifi technology provider that stands at $32.6m according to a securities filing.

Frequency Therapeutics is working on a progenitor cell-related treatment for hearing loss based on research conducted at MIT and Harvard Medical School.